Alexandria Real Estate Equities - REIT opened lower at $44.85, compared with its previous close of $45.08. In the last trading session, the stock traded between $44.18 and $45.32. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Alexandria Real Estate Equities - REIT is now worth
$ 21.54
Resulting in a loss of
$ 78.46 (78.46%)
Note: Past profits do not guarantee future returns.
Rating from 10 Analysts
Today's Change
$-0.79 (-1.76%)
Day High
$45.32
Day Low
$44.18
Day Open
$44.85
Prev Close
$45.08
Volume
10,43,461
1W Return
-3.57%
1M Return
0.38%
3M Return
-7.94%
6M Return
-3.73%
1Y Return
-19.26%
Market Cap ($ Mn)
7,713
PE Ratio
-
PB Ratio
0.57
PEG Ratio
-
ROE
-7.19%
ROCE
-2.88%
EPS (TTM)
$-3.74
1 Week
-3.57%
1 Month
0.38%
3 Months
-7.94%
6 Months
-3.73%
9 Months
-17.62%
RBC lowers Alexandria Real Estate price target to $47, keeps Sector Perform
RBC Capital lowered Alexandria Real Estate's price target from $51 to $47. Analyst Michael Carroll maintained a Sector Perform rating on the stock.
9 days agoAlexandria Real Estate closes $5.0 billion credit line with lower rates
Alexandria Real Estate Equities closed an amended $5.0 billion unsecured senior line of credit. Maturity extended from January 2030 to January 2032, subject to extension options. Borrowing rate reduced to SOFR plus 0.725%, a decrease of 11 bps. Agreement effective September 24, 2026, reinforcing long-term financial flexibility.
1mo agoAlexandria Real Estate highlights blood cancer innovation and philanthropy
Alexandria Real Estate Equities (NYSE: ARE) highlights its role in blood cancer innovation during Blood Cancer Awareness Month. Blood cancers account for 9.4% of new U.S. cancer cases in 2025, with diagnoses occurring every three minutes. Juno Therapeutics, a former tenant and early investee, helped advance Breyanzi® CAR-T therapy before being acquired by Celgene in 2018. Alexandria has partnered with nonprofits like MMRF since 2012 and supports employee volunteerism for blood and marrow donation.
2mo agoAlexandria Real Estate Q2 Results: FFO rises to $1.73
Alexandria Real Estate beat Q2 estimates with FFO of $1.73/share and sales of $662.784M, though both metrics fell YoY.
3mo agoAlexandria Real Estate Latest Results: FFO guidance narrows to $6.35-$6.45
Alexandria Real Estate narrows FY2026 FFO guidance to $6.35-$6.45, beating the $6.37 analyst estimate. The revised range replaces the previous $6.30-$6.50 outlook, reflecting tighter operational expectations and improved confidence in cash flow generation.
3mo agoAlexandria delivers 427,000 RSF R&D hub for Bristol Myers Squibb
Alexandria Real Estate Equities, Inc. delivered a 427,000 RSF R&D hub for Bristol Myers Squibb at its Campus Point Megacampus in San Diego. The campus, which was 95.4% occupied as of March 31, 2026, spans 2.9 million RSF with 1.3 million RSF in operation, 0.9 million RSF under construction, and 0.7 million RSF available for future development. The delivery reinforces Alexandria's decades-long partnership with BMS and its cluster-driven strategy in the San Diego region.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $247.35 | -0.13% | $1,81,458.43M | 106.76 | |
| $130.03 | -0.05% | $1,23,595.21M | 31.27 | |
| $1,068.06 | +1.72% | $1,05,725.12M | 67.21 | |
| $190.24 | -0.07% | $88,226.46M | 24.24 | |
| $234.75 | +0.12% | $75,953.83M | 15.14 | |
| $181.13 | +0.14% | $68,526.19M | 90.03 | |
| $335.73 | -0.06% | $62,728.80M | 29.94 | |
| $59.57 | +0.05% | $56,650.89M | 44.91 | |
| $64.63 | -1.70% | $50,009.34M | 25.14 | |
| $90.42 | +0.09% | $47,815.90M | 170.02 | |
| $89.06 | -0.32% | $37,893.34M | 30.95 | |
| $112.43 | +1.49% | $33,485.48M | 83.86 |
An investment of $100 made 5 years ago in Alexandria Real Estate Equities - REIT is now worth
$ 21.54
Resulting in a loss of
$ 78.46 (78.46%)
Note: Past profits do not guarantee future returns.
